BioCentury | Feb 2, 2009
Finance

Ebb & Flow

...Alexza (NASDAQ:ALXA) gained $0.06 to $2.89 after mutually terminating a deal to develop Staccato fentanyl ( AZ-003...
BioCentury | Feb 2, 2009
Company News

Alexza, Endo neurology, drug delivery news

...52 (33%) to about 104 and terminated its deal with Endo to develop Staccato fentanyl ( AZ-003...
BioCentury | Jan 31, 2009
Company News

Alexza restructures, ends deal with Endo

...to about 104 and mutually terminated a deal with Endo (NASDAQ:ENDP) to develop Staccato fentanyl ( AZ-003...
BioCentury | May 12, 2008
Regulation

Fentanyl pipeline

...cancer pain Ph II on hold; FDA requested more safety data Alexza (NASDAQ:ALXA)/ Endo (NASDAQ:ENDP) Staccato fentanyl...
BioCentury | Jan 7, 2008
Finance

Ebb & Flow

...last two weeks after granting Endo (NASDAQ:ENDP) exclusive rights to develop and commercialize Staccato fentanyl ( AZ-003...
BioCentury | Jan 7, 2008
Company News

Alexza, Endo deal

...Alexza granted Endo exclusive rights to develop and commercialize Staccato fentanyl ( AZ-003 ) in North America...
...to deliver fentanyl, is in Phase I testing to treat breakthrough pain. Alexza will manufacture Staccato fentanyl...
BioCentury | Dec 28, 2007
Company News

Endo in-licenses Alexza's AZ-003

...ALXA granted ENDP exclusive rights to develop and commercialize Staccato fentanyl ( AZ-003 ) in North America...
...to deliver fentanyl, is in Phase I testing to treat breakthrough pain. ALXA will manufacture Staccato fentanyl...
BioCentury | Aug 13, 2007
Product Development

Speedy delivery

...11 and 20 mins, 25%, 50% and 75% of AeroLEF patients reported effective analgesia Alexza Staccato fentanyl...
...Ph I compl; further development pending a partnership Ph I data in 50 pts: showed AZ-003...
BioCentury | Jan 1, 2007
Clinical News

Staccato fentanyl: Preliminary Phase I data

...of a Phase I trial in 50 healthy volunteers showed that the pharmacokinetics of inhaled AZ-003...
...of AZ-003 with multiple doses of fentanyl. Alexza Pharmaceuticals Inc. (ALXA), Palo Alto, Calif. Product: Staccato fentanyl...
...with multiple doses of fentanyl. Alexza Pharmaceuticals Inc. (ALXA), Palo Alto, Calif. Product: Staccato fentanyl ( AZ-003...
BioCentury | Dec 11, 2006
Strategy

Alexza's crescendo

...deal were ALXA's two other Staccato products: Staccato prochlorperazine ( AZ-001 ) and Staccato fentanyl ( AZ-003...
...AZ-003 ). Staccato prochlorperazine is in Phase IIb testing to treat acute migraine, while Staccato fentanyl...
Items per page:
1 - 10 of 11